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Abdominal aortic aneurysm (AAA) is a potentially lethal disease associated with immune activation-induced aor-
tic degradation. We hypothesized that xenotransplantation of human adipose-derived stem cells (hADSCs) would 
reduce aortic inflammation and attenuate expansion in a murine AAA model. Modulatory effects of ADSCs on 
immune cell subtypes associated with AAA progression were investigated using human peripheral blood mono-
nuclear cells (hPBMNCs) cocultured with ADSCs. Murine AAA was induced through elastase application to the 
abdominal aorta in C57BL/6 mice. ADSCs were administered intravenously, and aortic changes were determined 
by ultrasonography and videomicrometry. Circulating monocytes, aortic neutrophils, CD28− T cells, FoxP3+ regu-
latory T cells (Tregs), and CD206+ M2 macrophages were assessed at multiple terminal time points. In vitro, 
ADSCs induced M2 macrophage and Treg phenotypes while inhibiting neutrophil transmigration and lymphocyte 
activation without cellular contact. Intravenous ADSC delivery reduced aneurysmal expansion starting from day 4 
[from baseline: 54.8% (saline) vs. 16.9% (ADSCs), n = 10 at baseline, n = 4 at day 4, p < 0.001], and the therapeutic 
effect persists through day 14 (from baseline: 64.1% saline vs. 24.6% ADSCs, n = 4, p < 0.01). ADSC administra-
tion increased aortic Tregs by 20-fold (n = 5, p < 0.01), while decreasing CD4+CD28− (−28%), CD8+CD28− T cells 
(−61%), and Ly6G/C+ neutrophils (−43%, n = 5, p < 0.05). Circulating CD115+CXCR1−LY6C+-activated mono-
cytes decreased in the ADSC-treated group by day 7 (−60%, n = 10, p < 0.05), paralleled by an increase in aortic 
CD206+ M2 macrophages by 2.4-fold (n = 5, p < 0.05). Intravenously injected ADSCs transiently engrafted in the 
lung on day 1 without aortic engraftment at any time point. In conclusion, ADSCs exhibit pleiotropic immuno-
modulatory effects in vitro as well as in vivo during the development of AAA. The temporal evolution of these 
effects systemically as well as in aortic tissue suggests that ADSCs induce a sequence of anti-inflammatory cel-
lular events mediated by paracrine factors, which leads to amelioration of AAA progression.
Key words: Abdominal aortic aneurysm (AAA); Adipose-derived stem cells (ADSCs);  
Regulatory T cells (Tregs); M2 macrophage; Paracrine signaling
INTRODUCTION
Abdominal aortic aneurysm (AAA) is a multistep, 
initially asymptomatic process of excessive aortic 
inflammation-induced deterioration leading to progres-
sive aortic dilation, aortic rupture, and patient mortality1–3. 
The risk of aneurysm rupture increases exponentially 
with the aortic diameter and is associated with mortal-
ity of more than 80% despite emergency surgical repair4. 
Unfortunately, no therapeutic options have been dem-
onstrated to retard the growth of aneurysms, so current 
treatment is limited to elective or emergent endovascular 
or open surgical repair of larger aneurysms5–8. Excessive 
aortic inflammation is a key pathogenic factor responsi-
ble for the development of aneurysms9–11. It is character-
ized by activation of circulating monocytes12,13; release of 
proinflammatory cytokines14,15; local aortic infiltration by 
neutrophils, macrophages, and lymphocytes16–18; and sub-
sequent degradation of the extracellular matrix (ECM) by 
macrophage- and neutrophil-derived proteases19–23.
Among the several immune cells involved in the patho-
genesis of AAA, subtypes of T cells, in particular, have 
been shown to play key roles in early aortic inflammation, 
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which promotes degradation of the ECM in AAA24–26. 
Specifically, AAA patients with small aneurysms, early in 
their clinical course, have a high prevalence of circulating 
as well as aortic CD4+CD28− and CD8+CD28− T cells27 
and a paucity of anti-inflammatory CD4+CD25+Foxp3+ 
regulatory T cells (Tregs)28. Similarly, in animal mod-
els, Treg depletion or deficiency has been shown to 
exacerbate aneurysm formation, whereas viable Treg 
supplementation inhibits AAA development29. Overall, 
these observations highlight the importance of adequate 
Treg activity to balance CD28− T cells in AAA initiation 
and development.
In the past decade, administration of mesenchymal 
stem cells (MSCs) has emerged as a promising thera-
peutic modality to modulate inflammatory responses 
in a wide range of pathologies. Bone marrow (BM)- 
and placenta-derived MSCs have shown promise in 
limiting overall AAA expansion in animal models, 
although the precise modulation of monocytes, M2 
macrophages, Tregs, and CD28− T cells by MSCs has 
not been thoroughly investigated30–35. More recently, 
adipose-derived MSCs or adipose-derived stem cells 
(ADSCs) have been recognized as readily available 
in adequate numbers to permit practical autologous 
treatment. ADSCs derived from liposuction can be 
immediately administered upon isolation at the point 
of care or after only a few days of culture. ADSCs have 
been reported to induce Treg phenotype and suppress 
lymphocyte proliferation in vitro36–38. However, their 
paracrine modulation of transendothelial neutrophil 
migration or immune subtypes has not been explored, 
particularly in the context of AAA.
In this article, we determined that ADSCs modulate 
neutrophil transmigration as well as lymphocyte, mono-
cyte, and macrophage phenotypes both in vitro and in vivo. 
Moreover, ADSC administration limited topical elastase-
induced aortic inflammation and aneurysm expansion in 
our murine model. We attributed these effects to para-
crine factors released from ADSCs transiently trapped in 
the lung without aortic engraftment.
MATERIALS AND METHODS
All procedures for collecting human tissues (peripheral 
blood and adipose tissue) were approved by the Indiana 
University School of Medicine Institutional Review 
Board (IRB).
Human Adipose-Derived Stem Cells
Human ADSCs (hADSCs) were isolated by the sub-
cutaneous liposuction of adipose tissue, as previously 
described39. Briefly, adipose tissue was digested in col-
lagenase type I solution (Worthington Biochemical, 
Lakewood, NJ, USA) with agitation for 1 h at 37°C 
followed by 250 µm Nitex filtration (Sefar America, 
Buffalo, NY, USA) and centrifugation at 300 × g for 
8 min to separate the stromal cell fraction (pellet) from 
adipocytes. The stromal fraction was then suspended 
in cell lysis buffer [154 mM NH4Cl, 10 mM KHCO3, 
and 0.1 mM ethylenediamine-tetraacetic acid (EDTA); 
Thermo Fisher Scientific, Waltham, MA, USA] for 
5 min at 37°C and centrifuged at 300 × g for 5 min. The 
stromal pellet was suspended and cultured in microvas-
cular endothelial cell growth medium-2 (EGM-2MV) 
media (Lonza, Allendale, NJ, USA) and passaged at 
60%–80% confluence. ADSCs with Hoechst labeling 
were used (Invitrogen, Carlsbad, CA, USA) at passages 
3 to 5. The hADSCs were suspended in phosphate-
buffered saline (PBS; Thermo Fisher Scientific) for use 
in vivo. ADSCs isolated using this method were positive 
for CD90, CD73, CD105, and CD44 and negative for 
CD106, CD45, and CD31, as described previously40.
Human ADSC conditioned media (ADSC-CM) was 
generated by 20 ng/ml recombinant human tumor necro-
sis factor-a (TNF-a; R&D Systems, Minneapolis, MN, 
USA) activation for 24 h. Following this activation, cells 
were washed and allowed to recover for an additional 
24 h in fresh endothelial growth basal medium (EBM2) 
(Lonza) before ADSC-CM collection.
In Vitro Experiments
To isolate human neutrophils and peripheral blood 
mononuclear cells (PBMNCs), peripheral blood was 
isolated from healthy donors and processed with Ficoll-
Paque Plus (GE Healthcare Life Sciences, Pittsburgh, 
PA, USA), according to the manufacturer’s instructions. 
Briefly, blood plasma was removed, and the leukocyte-
rich upper layer was transferred and diluted with 30 ml 
of Hank’s balanced salt solution (HBSS; Thermo Fisher 
Scientific). The suspension was then layered onto 15 ml 
of Ficoll-Paque Plus (GE Healthcare Life Sciences) and 
centrifuged into its respective layers: plasma, PBMNCs, 
Ficoll-Paque Plus, neutrophils, and erythrocytes. The 
PBMNC and neutrophil layers were collected and incu-
bated in erythrocyte lysis buffer for 10 min, washed twice, 
and immediately used.
To study macrophage polarization, 1 × 106 hPBMNCs 
were incubated with 3 × 104 or 3 × 105 ADSCs on Trans-
well inserts for 3 days with or without 20 ng/ml TNF-a. 
Cells that adhered to the bottom of the plate were then 
isolated and resuspended for fluorescein isothiocyanate 
(FITC)-CD68 and phycoerythrin (PE)-CD206 (BD Bio-
sciences, San Jose, CA, USA) flow cytometry, as previ-
ously described41.
To study Treg induction, hPBMNCs were incubated 
with ADSCs on Transwell inserts for 5 days. Cells that 
adhered to the bottom plate were then isolated and 
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resuspended for FITC-CD4, allophycocyanin (APC)-
CD25, and PE-FoxP3 (BD Biosciences) flow cytometry.
Neutrophil transmigration was determined using Trans-
well plating in which inserts coated with a confluent mono-
layer of human umbilical cord endothelial cells (HUVECs) 
were placed above a bottom chamber with human ADSCs. 
CellTrace™ carboxyfluorescein succinimidyl ester (CFSE; 
Invitrogen)-labeled human neutrophils were loaded into the 
upper chamber, and migration was monitored in response 
to 4–6 h of human TNF-a (20 ng/ml) treatment (Eclipse 
Ti; Nikon, Melville, NY, USA).
To measure lymphocyte proliferation, hPBMNCs 
were stimulated for 6 days at 37°C/5% CO2 with 
mouse anti-human CD3 (1 µg/ml; BD Biosciences) and 
mouse anti-human CD28 (0.5 µg/ml; BD Biosciences). 
[3H]Thymidine (0–5 mCi/well) was then added 18 h prior 
to measuring [3H]thymidine incorporation.
Animals
Animal studies were approved by the Institutional 
Animal Care and Use Committee (IACUC) of Indiana 
University. To generate our AAA model, 8- to 12-week-
old male C57BL/6 mice (Harlan, Indianapolis, IN, 
USA) were anesthetized with isoflurane (Thermo Fisher 
Scientific), and a midline abdominal incision was made 
to expose the abdominal aorta between the renal artery 
and the iliac bifurcation. An aneurysm was induced by 
placing an absorbable gelatin sponge (Pfizer, New York 
Figure 1. Time-dependent topical elastase-induced murine aneurysm formation. (A) Representative videomicrometry of progressive 
abdominal aortic expansion following topical elastase treatment. (B) A linear correlation between ultrasound- and videomicrometry-
measured aortic diameter (n = 22, R2 = 0.8473).
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City, NY, USA) containing 47 U/ml porcine elastase 
solution (Sigma-Aldrich, St. Louis, MO, USA) to the top of 
the exposed aorta (Fig. 1). The abdominal wall and skin 
were then closed with sutures. Two hours after surgery, 
mice were administered either vehicle (PBS) or 106 
Hoechst-labeled hADSCs through tail vein injection42,43. 
Changes in the abdominal aorta were determined by 
ultrasound (VisualSonics, Ontario, Canada) at baseline 
and on days 1, 4, 7, and 14. The diameters were objec-
tively measured by the same examiner blinded to the 
treatment assignment.
Histology and Immunohistochemistry
Animals were systemically perfusion fixed through 
the left ventricle using 4% paraformaldehyde (PFA; 
Sigma-Aldrich). The harvested abdominal aorta, between 
the renal artery and the iliac bifurcation, was further fixed 
overnight in 4% PFA followed by paraffin embedding for 
sequential sectioning (Fig. 2). The sequential sections 
were stained with either hematoxylin and eosin (H&E; 
Thermo Fisher Scientific), Masson’s trichrome (Sigma-
Aldrich), or Verhoeff–VanGieson (Sigma-Aldrich) for 
inflammatory cell infiltration, collagen, and elastin con-
tent, respectively.
Aortic M2 macrophage and Treg levels were deter-
mined by immunohistochemistry as previously descri-
bed44,45. Briefly, aortic sections were deparaffinized and 
ethanol rehydrated followed by citrate buffer (Thermo 
Fisher Scientific)-mediated antigen retrieval. Once pro-
cessed, the sections were blocked with A protein block 
(Abcam, Cambridge, MA, USA) and exposed to either: 
1:100 rabbit polyclonal CD68 (Abcam), 1:200 rabbit 
polyclonal CD206 (Biorbyt, Berkeley, CA, USA), 1:200 
rabbit polyclonal CD3 (Abcam), or 1:200 rat anti-mouse 
FoxP3 (eBiosciences, San Diego, CA, USA). Sections 
were developed using the biotin–avidin/streptavidin 
Figure 2. Hematoxylin and eosin (H&E) staining of the abdominal aorta was performed on sequential sections. Abdominal aorta 
between the renal artery and iliac bifurcation was harvested, fixed, paraffin embedded, and sequentially sectioned with 300 µm dis-
tance between sections. H&E staining demonstrated a sinusoidal pattern of aortic wall thickening and inflammation reflecting their 
proximity to the aneurysmal center.
FACING PAGE
Figure 3. Human ADSCs induce M2 macrophages, inhibit neutrophil transmigration, and suppress lymphocyte activation in vitro. 
(A) Adipose-derived stem cells (ADSCs) increased the percentage of M2 macrophages (CD14+CD206+/total CD14+) in human 
peripheral blood-derived mononuclear cell (PBMNC) 3-day Transwell cultures with or without tumor necrosis factor-a (TNF-a) in a 
concentration-dependent manner. (B) Representative flow cytometry plot. (C) ADSCs cocultured with human PBMNCs had an increased 
percentage of regulatory T cells (Tregs). (D) Representative CD4-gated flow cytometry plot. (E) Neutrophil transmigration assay car-
toon. (F) ADSCs inhibited TNF-a-induced neutrophil migration across an endothelial cell (EC) monolayer. (G) Carboxyfluorescein 
succinimidyl ester (CFSE)-labeled neutrophils. (H) ADSCs and ADSC-conditioned media (ADSC-CM) dose-dependently attenu-
ated anti-CD3- and anti-CD28-activated human PBMNC proliferation compared to nonactivated PB-MNCs. ap < 0.05 versus control; 
bp < 0.05 versus vehicle. n = 3–4/group. (A, F, H) ANOVA with post hoc Newman–Keuls test; (C) Student’s t-test.
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system (Vector Laboratories, Burlingame, CA, USA). 
Cells were counterstained with peroxidase substrate 3,3¢-
diaminobenzidine (DAB; Sigma-Aldrich) and/or hema-
toxylin (Sigma-Aldrich).
RNA Extraction and Quantitative Real-Time PCR
Warm saline was flushed through the left ventricle of 
the animals, after which the abdominal aorta was rapidly 
excised and snap frozen in liquid nitrogen. Total RNA 
was extracted from aortic tissue homogenates using 
the RNeasy mini kit (Qiagen, Valencia, CA, USA) fol-
lowing the manufacturer’s instructions. Reverse tran-
scription was performed with the High-Capacity cDNA 
Archive Kit (Applied Biosystems, Foster City, CA, USA) 
and real-time polymerase chain reaction (PCR) with 
the SYBR Green Master Mix (Applied Biosystems). 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
was used as an internal control46.
Flow Cytometry
Freshly isolated mouse aortic tissue was minced 
and incubated for 15 min with 37°C collagenase type 
IA (1 mg/ml; Sigma-Aldrich) dissolved in PBS with 
0.5% bovine serum albumin (BSA; GE Healthcare) and 
2 mmol/L EDTA. Cell viability was determined by try-
pan blue (Thermo Fisher Scientific) light microscopy 
followed by anti-mouse CD16/CD32 (1 µg/ml; eBiosci-
ences) blocking and antigen labeling for CD115, CD25, 
FoxP3 (eBiosciences), Ly6C, CD4, CD8, CD28, Ly6-G/C 
(BD Biosciences), or CX3CR1 (R&D Systems). Flow 
cytometry was performed on a Guava 8HT (Millipore, 
Billerica, MA, USA). Data were analyzed using FlowJo 
software (Tree Star, Ashland, OR, USA).
Human Alu Sequence DNA Extraction  
and Real-time PCR
The right lungs of mice treated with hADSCs were 
harvested at day 1 or 4. Genomic DNA was isolated using 
the Wizard Genomic DNA purification kit (Promega, 
Madison, WI, USA) following the manufacturer’s instruc-
tions. Human Alu sequence real-time PCR was per-
formed as previously described43. A standard curve for 
hADSCs was generated by adding serial ADSC dilutions 
to control mouse lung tissue before homogenization and 
DNA extraction.
Statistical Analysis
Statistical analysis was performed using GraphPad 
Prism software (La Jolla, CA, USA). Data are presented 
as mean ± standard error of the mean (SEM). Differences 
between groups were examined using Student’s unpaired 
t-tests or two-way analysis of variance (ANOVA). Post 
hoc Newman–Keuls tests identified differences between 
groups. Values of p < 0.05 were considered significant.
RESULTS
Human ADSCs Induce In Vitro M2 Macrophage 
Polarization and Treg Phenotype, Inhibit Neutrophil 
Transmigration, and Suppress Lymphocyte 
Activation Through Paracrine Mechanisms
Excessive inflammation is one of the defining char-
acteristics of AAA. It is associated with prominent M1 
macrophage polarization, Treg depletion, neutrophil trans-
migration, and lymphocyte activation2. We found that, 
indeed, hADSCs were able to modulate these inflamma-
tory cellular events in vitro in a dose-dependent manner. 
Human PBMNC-derived macrophages were cocultured 
in Transwells with hADSCs for 3 days. Following incu-
bation, the addition of TNF-a induced a significant 83% 
reduction in CD206+ M2 macrophages when compared 
to nontreated controls. Importantly, this was reversed in 
a dose-dependent manner by ADSC coculture (−58% vs. 
control in 3 × 104 ADSC group, and +116% vs. control in 
3 × 105 ADSC group) (Fig. 3A and B). In parallel experi-
ments, the presence of ADSCs induced a 2.5-fold increase 
in anti-inflammatory Tregs by day 7 (Fig. 3C and D). 
Additionally, we employed TNF-a as a chemoattractant 
to induce neutrophil transmigration across a confluent 
Transwell monolayer of HUVECs. Results demonstrated 
that ADSCs placed in the bottom of a Transwell reduced 
neutrophil transmigration by nearly 70% (Fig. 3E–G).
To determine the effect of ADSCs on lymphocyte 
proliferation, we added either ADSC- or TNF-a-treated 
ADSC conditioned medium (ADSC-CM) to an hPBMNC 
culture in the presence or absence of anti-CD3 and CD28 
antibodies47. ADSCs as well as ASC-CM markedly inhib-
ited lymphocyte proliferation in a dose-dependent man-
ner (Fig. 3H).
Collectively, studies present ADSCs as pleiotropic 
immunomodulators of macrophages, neutrophils, and lym- 
phocytes, in a cell contact-independent manner. In the 
context of AAA, this suggests that the presence of ADSCs 
may limit cytotoxic lymphocyte activation and the neu-
trophil infiltration48 associated with the development of 
abdominal aortic aneurysm in vivo.
Human ADSCs Suppress Elastase-Induced 
AAA Expansion
Previous studies have revealed that the vasa vasorum 
of the aortic tunica adventitia layer represent an impor-
tant source of infiltrating inflammatory cells2,49–52. The 
chronic nature of this inflammation initiates and drives 
the progressive degradation of aortic collagen along 
with extracellular matrix elastin fragmentation53. To 
simulate this abluminal mechanism of injury, we induced 
murine aortic inflammation by applying topical elastase 
to the aortic adventitia in absorbable gelatin foam. As 
anticipated and observed in human AAA specimens, the 
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Figure 4. Human ADSC treatment results in reduced periaortic inflammation, and greater preservation of elastin and collagen within the 
aortic wall in an elastase-induced murine abdominal aortic aneurysm (AAA) model. Representative (A) H&E, (B) elastin, and (C) Masson’s 
trichrome staining of ADSC- and control (PBS)-treated abdominal mouse aneurysms on days 1, 4, and 7. Scale bars: 100 µm.
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adventitial presence of elastase led to massive infiltration 
of inflammatory cells by day 7 (Fig. 4). The severity of 
this aortic inflammation was confirmed by the progressive 
expansion of abdominal aorta as seen through ultrasound 
(Fig. 5A) and videomicrometry (Fig. 1). Remarkably, a 
single injection of hADSCs significantly suppressed this 
expansion as early as day 4 [aortic diameter increase 
from baseline: 54.8% (saline) vs. 16.9% (ADSCs), n = 
4/group, p < 0.001]. Such therapeutic effect of hADSCs 
persisted through the end of the study period on day 14 
(aortic diameter increase from baseline 64.1% saline vs. 
24.6% ASDCs, n = 4/group, p < 0.01) (Fig. 5B). Overall, 
these results demonstrated that a single IV injection of 
hADSCs was sufficient to limit aortic diameter expansion 
following AAA initiation in this model.
Human ADSCs Induce a Rapid Aortic Surge in 
Foxp3+ Tregs With a Corresponding Decline in 
Inflammatory CD28− T Cells and Neutrophils
AAA patients experience a deficiency in aortic Tregs 
with an accompanying prevalence of CD28− T cells and 
neutrophils27,28. We determined that these features were 
present in our murine model of AAA and were reversible 
in the presence of ADSCs. Consistent with our in vitro 
studies, ADSCs induced a rapid and significant 20-fold 
surge in aortic Tregs (Fig. 6A and B) compared to con-
trols. This was associated with a marked repression of the 
total aortic T-cell population by 58% and 75% at days 1 
and 4, respectively (Fig. 6C). Notably, the initial induc-
tive effect of ADSCs on Treg was weakened over 7 days 
after the initial cell delivery, which is consistent with loss 
of suppression on total T cells at day 7 by ADSCs, likely 
reflecting a diminishing effect of ADSCs 7 days after the 
initial dose of injection. Other inflammatory cell popula-
tions demonstrated responses to ADSC injection similar 
to those found for the total T-cell population. At day 1, the 
CD4+CD28− and CD8+CD28− T-cell subsets were already 
significantly decreased by 28% and 61%, respectively 
(Fig. 7A). This was accompanied by a 43% decrease in 
Ly6G/C+ neutrophil infiltration (Fig. 7B and C). The early 
ADSC-induced increase in the AAA aortic Treg content 
with concurrent inhibition of CD28− T-cell and neutrophil 
infiltration likely contributed to the observed day 4 sup-
pression of aortic expansion.
Human ADSCs Reduce Circulating Proinflammatory 
Monocytes and Polarize Aortic Macrophages 
Toward the M2 Subtype
Systemic circulation contributes to the initial AAA 
inflammatory response by delivering monocytes to the site 
of aortic inflammation16 with proinflammatory M1 macro-
phages defining the majority of the AAA-stimulated inflam-
matory cell infiltration54. In our topical elastase-induced 
AAA model, we observed that the presence of ADSCs 
progressively reduced the circulating levels of proinflam-
matory CD115+CXCR1−LY6C+ monocytes, with signif-
icance achieved by day 7 (Fig. 8A and B). The loss of 
significance between the two treatment groups by day 14 
is likely a consequence of resolving systemic inflamma-
tory response to the initial elastase insult in the context of 
a small sample size. This reduction in circulating mono-
cytes was associated with aortic resident macrophage 
polarization toward the reparative M2 subtype (CD206+) 
(Fig. 8C–E). Collectively, these results suggest that early 
ADSC intervention may be a clinically relevant therapeutic 
means of modulating the initial inflammatory components 
linked to exacerbation of abdominal aortic aneurysm.
Intravenous ADSC Administration Leads to 
Transient Lung Trapping Without Aortic Engraftment
Hoechst-labeled ADSCs were injected into the tail vein 
of control and AAA-induced mice. Consistent with other 
observations46,55, the biodistribution of the 1 × 106 ADSCs 
that were injected exhibited predominant pulmonary local-
ization on day 1 with no engraftment at the site of aortic 
injury (Fig. 9A). ADSC lung entrapment measured at 24 
and 96 h postinjection demonstrated a time-dependent 
decrease in concentration. ADSC entrapment in lungs was 
quantified using a standard curve of in vitro mixed mouse 
lung tissue titrated with hADSCs. This curve could detect 
~1,000 cells/bilateral lungs or as low as 0.01% of the 
delivered IV dose (Fig. 9B). Quantitatively, an average of 
3% (up to 15% in some individuals) of the delivered cells 
were retrievable from the lungs by 24 h, whereas less than 
0.5% could be retrieved by 48 h (Fig. 9C).
DISCUSSION
To date, no reports on the effect of ADSCs on neu-
trophil transmigration have been published, and there are 
limited studies on M2 macrophage56 and Treg36,37 induc-
tion. Moreover, none have demonstrated the potential 
involvement of ADSC-mediated paracrine factors in these 
activities. Our results suggest that ADSC paracrine sig-
naling may be a useful immunomodulatory element in the 
regulation of AAA expansion. Using both in vitro and in 
vivo experiments, we demonstrated that ADSCs can posi-
tively regulate macrophage polarization toward the M2 
reparative phenotype, inhibit neutrophil transmigration, 
and induce the aortic expression of immunosuppressive 
Foxp3+ Tregs in a murine model of AAA. Consistent with 
the literature38,57, the presence of ADSCs after aneurysms 
reduced the level of circulating levels of proinflammatory 
CD115+CXCR1−LY6C+ monocytes.
In testing the influence of ADSC conditioned media 
on cellular inflammatory characteristics, we found that, 
indeed, ADSC conditioned media (ADSC-CM) gener-
ated from TNF-a-stimulated ADSCs can suppress CD3/
CD28 Ab-induced lymphocyte proliferation compared 
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to conditioned medium from unstimulated ADSCs. The 
TNF-a-stimulated ADSC-CM was able to dose-depend-
ently inhibit lymphocyte proliferation, indicating that the 
cellular environment has a significant role in determining 
ADSC immunomodulatory activities. Taken together, these 
results robustly support the idea that ADSC-mediated para-
crine factors exert a therapeutic, immunomodulatory effect 
in aortic inflammation.
AAA development and expansion are relatively rapid in 
models of AAA compared to the chronic clinical course of 
aneurysm development in human patients58. This dichot-
omy raises the question of how accurately AAA models 
may predict human clinical disease progression and out-
comes1. Despite this, each model offers mechanistic and 
therapeutic insight into key pathological components asso-
ciated with AAA development and progression. Given the 
importance of the adventitial layer and its vasa vasorum in 
mediating inflammatory cell infiltration49,59,60, we selected 
a topical elastase-based approach to experimentally 
induce aortic inflammation and subsequent expansion61. 
Figure 5. Human ADSCs suppress elastase-induced AAA expansion in C57BL/6 mice. (A) Mouse aortic ultrasound images at base-
line and days 4, 7, and 14 post-elastase treatment, in conjunction with administration of either vehicle or 1 × 106 human ADSCs [intra-
venous (IV)]. (B) ADSCs significantly suppressed murine elastase-induced aortic expansion starting from day 4 and persistently until 
day 14, compared to vehicle (n = 4–10/group, **p < 0.01 Student’s t-test).
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Figure 6. Human ADSCs increased the abdominal aortic ratio of Foxp3+ Tregs to CD3+ T cells in our model of AAA. (A) Representative 
immunohistochemical (IHC) staining of CD3 (total T cells) and FoxP3 (Tregs) for murine AAA on day 7. (B) Total CD3+ and FoxP3+ 
cells in the entire tunica adventitia and media layers were counted by microscopy of entire aortic sections at the point of maximal aortic 
circumference. The percentages of Tregs among total T cells were persistently increased by ADSCs throughout the first 7 days after 
cell injection. (C) Quantification of the density of total T cells showed suppression of T-cell infiltration by ADSCs in the early stage of 
AAA development. Arrows indicate positively stained cells (n = 4–5/group, *p < 0.05, **p < 0.01, Student’s t-test).
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Figure 8. Human ADSCs reduced circulating proinflammatory monocytes and polarized aortic macrophages to the M2 subtype. (A, B) ADSCs 
significantly decrease the ratio of inflammatory monocytes (CD115+Ly6C+CX3CR1−) to resident monocytes (CD115+Ly6C−CX3CR1+) by 
day 7 in AAA mouse peripheral blood, compared to control. (C) Day 7 AAA IHC staining for CD68 and CD206. Scale bar: 50 µm. (D, E) 
ADSCs provided a significant increase in the day 7 CD206+/CD68+ (M2/total) macrophage ratio, with a corresponding day 7 decrease in total 
(CD68+) macrophages. (B) n = 6–10/group, *p < 0.05 (D, E) n = 3–5/group. *p < 0.05 versus PBS group, Student’s t-test.
Figure 9. Intravenously administered ADSCs were not found frequently in the aorta and were transiently trapped in lung tissue. 
(A) Fluorescence imaging of lung (top) and aorta (bottom) showing presence of Hoechst-labeled human ADSCs on days 1 and 4. Scale 
bar: 50 µm. (B) Human Alu polymerase chain reaction (PCR) sequence curve showing a linear correlation between Ct value and human 
ADSC number in the mouse lung. (C) Less than 1% of human-infused ADSCs were detected in the day 4 mouse (n = 5–8/group).
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The resulting inflammatory cell infiltration from the vasa 
vasorum has been shown to mimic observations in human 
aneurysms62–65. We further optimized this approach using 
Gelfoam-mediated periadventitial elastase application 
to specifically focus on early adventitial inflammation. 
Our objective was to determine if the anti-inflammatory 
effects of ADSCs could limit the inflammatory initiation 
and early growth of small aneurysms. We determined that 
topical elastase potently stimulated and sustained abdomi-
nal aortic aneurysm formation. This method has the advan-
tage of avoiding aortic mechanical or needle injuries with 
a complimentary reduction in postoperative complications 
(<10%) and mortality (<5%). This rapid and reproducible 
method generated an aorta-specific inflammatory envi-
ronment in which the sequential modulation of cellular 
and peripheral inflammatory events could be studied in 
response to ADSC administration.
We found that aortic topical elastase application pro-
duced massive inflammatory cell infiltration in the vasa 
vasorum as well as degradation of collagen and elastin 
fibers by day 7 (Fig. 4). In monitoring the expected sequen-
tial aortic changes, we focused on the early, first week, 
time points as opposed to previous chronic studies31,34,66. 
Our rationale is that a detailed temporal delineation of 
the early AAA inflammatory27 events may lead to thera-
peutic innovations to limit aneurysmal progression at 
early stages. We demonstrated that IV injection of 1 × 106 
hADSCs at the time of early aneurysm formation gener-
ated a rapid surge in Tregs on day 1 with a correspond-
ing decline in CD28− T cells. This, in conjunction with 
the subsequently observed (day 4) suppression of aortic 
expansion, suggests a central role of early aortic inflam-
mation in the pathogenesis of aneurysm development. 
This novel observation provided us an avenue by which to 
mechanistically study the involvement of CD28− T cells 
and Tregs in the development of AAA.
Recent evidence has also elucidated a role for mono-
cytes in the evolution of large aneurysms40. Our end-
point analysis found that the presence of hADSCs after 
AAA decreased the levels of circulating monocytes. ADSC 
administration significantly decreased the circulating lev-
els of CD115+Ly6C+CX3CR1− inflammatory monocytes 
com pared to CD115+Ly6C−CX3CR1+ resident monocytes 
(Fig. 7). This was further supported by the parallel increase 
in aortic anti-inflammatory M2 macrophages by day 7 
(Fig. 8). The contribution of M2 macrophages to the ame-
lioration of AAA has only recently come to light through 
the modulation of peroxisome proliferator-activated recep-
tor-g (PPAR-g) and Notch signaling inhibition67,68. We 
are the first to demonstrate that ADSCs may influence 
the activity of M2 macrophages in the context of AAA. 
Our consistent observation of ADSC-mediated M2 mac-
rophage upregulation and complementary Treg produc-
tion with the terminal suppression of aneurysm expansion 
presents immunomodulation as an important therapeutic 
approach to limiting AAA progression.
To ascertain ADSC biodistribution in the context of 
AAA therapy, we measured ADSC aortic engraftment and 
lung entrapment. Consistent with other animal models69–73, 
we found that IV ADSC delivery resulted in the distribu-
tion of ADSCs predominantly in the lungs with minimal 
aortic engraftment (Fig. 9A). Consistent with observations 
in previous studies30–35, our findings highlighted the thera-
peutic importance of ADSC paracrine factors and para-
crine signaling as a major component of their regenerative 
capacity. Moreover, we found the presence of ADSCs 
in the lungs to be transiently cleared by day 4. This was 
consistent with a previous study wherein researchers 
assessed lung clearance of bone marrow-derived MSCs 
(BM-MSCs) in mice with myocardial infarction and 
showed that <0.1% of infused cells remained in the lungs 
after 96 h43. This acute cell clearance in contrast to the 
chronic suppression of aortic expansion over the course of 
2 weeks strongly supports the idea that an ADSC-mediated 
paracrine effect was therapeutically important. The local 
physical presence or aortic engraftment of ADSCs appears 
unnecessary to perpetuate changes in the aneurysm 
models of an inflammatory environment and suppresses 
AAA progression. A single ADSC dose of 1 × 106 was 
sufficient to modulate the AAA immune response and to 
upregulate Treg and M2 macrophage expression in this 
model. Concordantly, ADSCs downregulated monocyte 
activation, neutrophil transmigration, and circulating 
CD28− T-cell levels, thereby inhibiting aneurysm pro-
gression. Overall, our results call for future experiments 
examining the individual inflammatory components con-
tributing to the therapeutic effects of ADSCs for AAA.
CONCLUSION
A single IV injection of 1 × 106 ADSCs is sufficient to 
suppress abdominal aortic expansion in a topical elastase-
induced murine model of AAA. Periadventitial applica-
tion of elastase-soaked Gelfoam successfully induced 
AAA formation in mice and demonstrated an orchestrated 
activation of inflammatory monocytes, Tregs, and mac-
rophages, which is consistent with human AAA patients. 
The therapeutic effect was experimentally attributed to 
the early and immediate ADSC-mediated suppression 
of neutrophil transmigration and circulating lymphocyte 
activation following AAA. Importantly, the regenera-
tive potential of ADSCs was observed through the aor-
tic induction of M2 macrophages and Tregs. The infused 
ADSCs were predominantly localized to the lungs and 
did not engraft in the aortas of AAA models. This obser-
vation supports our hypothesis that ADSC-mediated 
paracrine factors modulate the AAA-induced inflamma-
tory response to suppress aneurysm expansion and AAA 
progression.
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AAA is a lethal disease with chronic progression lead-
ing to end-stage aneurysm rupture and an 80% mortal-
ity rate. Currently, AAA treatment options include open 
surgical and endovascular repair preceding rupture and 
are associated with significant morbidity, mortality, and 
expense. In this article, we present an early and proactive 
way to mediate and suppress aortic expansion through a 
single abdominal aortic stem cell infusion. The human 
ADSCs were readily accessed through minimally invasive 
liposuction procedures and isolated in large quantities, 
offering a novel and practical modality for autologous 
AAA treatment. AAA was induced by a single elastase-
containing gel foam application to the abdominal aorta in 
mice. Considerable dynamic and concerted systemic and 
aortic inflammatory cellular events were observed in the 
early stage of murine AAA development. This is consistent 
with what has been previously observed in AAA patients, 
but not reproduced or reported in animal models.
Importantly, these results demonstrate that ADSC infu-
sion, in our AAA model, produced an immunomodulatory 
shift in the animal and aortic tissue from a predomi-
nantly proinflammatory state to a tissue-reparative, anti- 
inflammatory state. This was observed through decreases 
in CD28− T cells, activated monocytes, neutrophils, and 
M1 macrophages, with corresponding increases in tissue- 
reparative Tregs and M2 macrophages. We propose that this 
feed-forward anti-inflammatory cascade prompted the sup-
pression of aortic expansion and aneurysm development.
Notably, results derived from both in vivo biodistribu-
tion studies and in vitro cell culture studies demonstrate that 
ADSC paracrine factors mediate the AAA anti-inflamma-
tory activity. This preclinical evidence of ADSC efficacy in 
the amelioration of early AAA inflammation and chronic 
expansion provides strong evidence for future studies and 
clinical trials using autologous ADSCs or ADSC-derived 
cellular products in the treatment of early stage small AAA.
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